48
DAFTAR PUSTAKA
1. Thebaud B, Mazmonteil TL. Patent ductus arteriosus in premature
infants: a never-closing act. Paediatr Child Health. 2010; 15(5):267-70
2. Hamrick SEG, Hansmann G. Patent ductus arteriosus of the preterm
infant. Pediatrics. 2010; 125:1020-30
3. Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J Pediatr
Pharmacol Ther. 2007;12:138-46
4. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation.
2006;114:1873-82
5. Nizarali Z, Marques T, Costa C, Barroso R, Cunha M. Patent ductus
arteriosus: perinatal risk factors. J Neonatal Biol. 2012; 1(3):1-4
6. Soeroso S, Sastrosoebroto H. Duktus arteriosus persisten. Dalam:
Sastrosoebroto H, Madiyono B, penyunting. Buku Ajar Kardiologi
Anak. Edisi pertama. Jakarta: Ikatan Dokter Anak Indonesia; 1994. h.
214-21
7. Vucovich MM, Cotton RB, Shelton EL, Goettel JA, Ehinger NJ, Poole
SD, Brown N, Wynn JL, Paria BC, Slaughter JC, Clark RH, Rojas MA,
Reese J. Aminoglycoside-mediated relaxation of the ductus arteriosus
in sepsis-associated PDA. Am J Physiol Heart Circ Physiol. 2014;
H732-40
8. Puopolo KM. Epidemiology of neonatal early onset of sepsis.
49
9. Polin RA. Management of neonates with suspected or proven
early-onset bacterial sepsis. Am Acad of Pediatr. 2012; 541:1006-15
10. Adams HR, Parker JL, Durrett. Cardiac toxicities of antibiotics. Environ
Health Perspectives. 1978; 26:217-23
11. Amrani LA, Green RS, Gluck KM, Lin J. Failure of a repeat course of
cyclooxygenase inhibitor to close a PDA is a risk factor for developing
chronic lung disease in ELBW infants. Pediatr. 2012; 12(10):1-7
12. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, dkk. Failure
of ductus arteriosus closure is associated with increased mortality in
preterm infants. Pediatr. 2009; 123:e138-44
13. Kluckow M. Oral ibuprofen and the patent ductus arteriosus: a new
approach to an old problem. J Pediatr. 2013; 89:4-5
14. Hariyanto D. Profil penyakit jantung bawaan di instalasi rawat inap
anak RSUP Dr.M.Djamil Padang Januari 2008 – Februari 2011. Sari
Pediatri. 2012; 14(3):152-7
15. Sjarif DR, Anggriawan SL, Putra ST, Djer MM. Anthropometric profiles
of children with congenital heart disease. Med J Indones. 2011;
20(1):40-5
16. Hady HA, Nasef N, Shabaan AE, Nour I. Patent ductus arteriosus in
preterm infants: do we have the right answer?. BioMed Res Int. 2013;
50
17. Ndubuisi OJM, Agarwal G, Raghavan A, Pham JT, Ohler KH,
Maheshwari A. Patent ductus arteriosus in premature neonates. Drugs.
2012; 72(7):907-16
18. Cotton RB, Shah LP, Poole SD, Ehinger NJ, Brown N, Shelton EL,
dkk. Cimetidine-associated patent ductus arteriosus is mediated via a
cytochrome P450 mechanism independent of H2 receptor antagonism.
J of Mol and Cell Cardiol. 2013; 59:86-94
19. Broadhouse KM, Finnemore AE, Price AN, Durighel G, Cox DJ.
Edwards AD, dkk. Cardiovascular magnetic resonance of cardiac
function and myocardial mass in preterm infants: a preliminary study of
the impact of patent ductus arteriosus. J of Cardiol Magnetic
Resonance. 2014; 16(54):1-9
20. Agarwai R, Deorari AK, Paul VK. Patent ductus arteriosus in preterm
neonates. Indian J of Pediatr. 2008; 75:277-308
21. Sasi A, Deorari A. Patent ductus arteriosus in preterm infants. Indian
Pediatr. 2011; 48:301-8
22. Saeidi R, Mahmoodi E, Eslami M, Gholami M. Evaluation of risk factors
related with neonatal patent ductus arteriosus in hospitalized neonates
of neonatal intensive care unit. Zahedan J of Res in Med Sci.2012;
14(6):33-5
23. Waleh N, Hodnick R, Jhaveri N, McConaghy S, Dagle J, Seidner S,
51
expression in the ductus arteriosus are related to environmental and
genetic risk factors for persistent ductus patency. Pediatr Res. 2010;
68(4):292-7
24. Shiao SYPK, Ou CN. Validation of oxygen saturation monitoring in
neonates. Am J Crit Care. 2007; 16(2): 168–78
25. Reese J, Veldman A, Shah L, Vucovich M, Cotton RB. Inadvertent
relaxation of the ductus arteriosus by pharmacological agents that are
commonly used in the neonatal period. Semin Perinatol. 2010;
34(3):222-30
26. Iwasaki S, Minamisawa S, Yokoyama U, Akaike T, Quan H,
Nagashima Y, dkk. Interleukin-15 inhibits smooth muscle cell
proliferation and hyaluronan production in rat ductus arteriosus. Pediatr
Res. 2007; 62(4):392-8
27. Departemen Kesehatan. Sepsis neonatorum. Jakarta: Pelayanan
Obstetri Dan Neonatal Emergensi Komprehensif (PONEK), 2008.
h.215-23
28. Ginsburg AS, Meulen AS, Klugman KP. Prevention of neonatal
pneumonia and sepsis via maternal immunization. Lancet. 2014; 2:
e679-80.
29. Chang GJ, Lae AC, Baqui AH, Tan J, Black RE. Risk of early-onset
neonatal infection with maternal infection or colonization: a global
52
30. Leal YA, Alvarez-Nemegyei J, Velazquez JR, Rosado-Quaib U,
Diego-Rodriguez N, Paz-Baeza E, dkk. Risk Factors and prognosis for
neonatal sepsis in southeastern Mexico: analysis of a four year historic
cohort follow-up. BMC Pregnancy and Childbirth. 2012; 12:48
31. Schleubner E. The prevention, diagnosis and treatment of premature
labor. Dtsch Arztebl Int. 2013; 110(13):227-35
32. Martin RJ, Crowley MA. Respiratory problems. Dalam: Klaus,
Fanaroff’s, penyunting. Care of the High-Risk Neonate. Edisi ke-enam.
Elseiver. 2013. h. 248-9
33. Gomella TL, Cunningham MD, Eyal FG, Tuttle DJ. Sepsis. Dalam:
Gomella TL, Cuningham MD, Eyal FG, Zenk KE, penyunting.
Management, Procedures, on-call problems, disease, and drugs. New
York: MC Graw-Hill; 2013. h.865-73
34. Satar M, Ozlu F. Neonatal sepsis: a continuing disease burden. The
Turkish J of Pediatr. 2012; 54:449-57
35. Alam MM, Saleem AF, Shaikh AS, Munir O, Qadir M. Neonatal sepsis
following prolonged rupture of membranes in a tertiary care hospital in
Karachi, Pakistan. J infect Dev Ctries. 2014; 8(1):067-73
36. West BA, Peterside O. Sensitivity pattern among bacterial isolates in
neonatal septicaemia in Port Harcout. Ann of Clin Microbiol and
53
37. Mezzatesta ML, Gona FL, Stefani S. Enterobacter cloacae complex:
clinical impact and emerging antibiotic resistance. Future Microbiol.
2012; 7:887-902
38. Engle WD, Jackson GL, Sendelbach DM, Stehel EK, Ford DM,
McHugh KM, dkk. Pneumonia in term neonates: laboratory studies and
duration of antibiotic therapy. J of Perinatol. 2003; 33:372-7
39. Testa M, Fanos V, Martinelli V, Stronati M, Mussap M, Delzompo M.
Therapeutic drug monitoring of gentamicin in neonatal. Intensive Care
Unit: experience in 68 newborns. J of Chemother. 2007; 19(2):39-41
40. Lundergan FS, Glasscock GF, Kim EH, Cohen RS. Once-daily
gentamicin dosing in newborn infants. Pediatr. 1999; 103(6):1228-34
41. Touw DJ, Proost JH, Stevens R, Lafeber HN, Weissenbruch V.
Gentamicin pharmacokinetics in preterm infants with a patent and
closed ductus arteriosus. Pharmacy World & Sci. 2001; 23(5):200-4
42. Tayman C, Rayyan M, Allegaert K. Neonatal pharmacology: extensive
interindividual variability despite limited size. J Pediatr Pharmacol Ther.
2011; 16(3):170-84
43. Gal P. Optimum use of therapeutic drug monitoring and
pharmacokinetics-pharmacodynamics in the NICU. J Pediatr
Pharmacol Ther. 2009; 14:66–74
44. Adams HR, Durrett LR. Gentamicin blockade of slow Ca++ channels in
54
45. Thebaud B, Wu XC, Kajimoto H, Bonnet S, Hashimoto K, Michelakis
ED, Archer SL. Developmental absence of the O2 sensitivity of L-type
calcium channels in preterm ductus arteriosus smooth muscle cells
impairs O2 constrictioncontributing to patent ductus arteriosus. Pediatr
Res. 2008; 63(2):176-81
46. Lullman H, Schwarz. Effects of aminoglycoside antibiotics on bound
calcium and concentration in guinea-pig atria. Br J Pharmac. 1985;
86:799-803
47. Sinha B. Contoversies in management of patent ductus arteriosus in
the preterm infant. J Pulmon Resp Med. 2013; S13(007):1-5
48. Poon G. Ibuprofen lysine (neoprofen) for the treatment of patent ductus
arteriosus. Proc (Bayl Univ Med Cent). 2007; 20:83-5
49. Dice JE, Bhatia J. Patent ductus arteriosus: an Overview. J Pediatr
Pharmacol Ther. 2007; 12(3):138-46
50. Siassi B, Biance C, Cabal LA, Coran AG. Incidence and clinical
features of patent ductus arteriosus in low-birthweight infants: a
prospective analysis of 150 consecutively born infants. Pediatr. 1976;
57(3): 347-51
51. Amirullah A. Sepsis pada bayi baru lahir. Dalam: Kasim SM, Yunanto
A, Dewi R, Sarosa IG, Usman A, penyunting. Buku ajar neonatologi.
55
52. Gomella TL, Cuningham MD, Eyal FG, Zenk KE. Infectious Disease.
Dalam: Gomella TL, Cuningham MD, Eyal FG, Zenk KE, penyunting.
Management, procedures, on-call problems, disease and drugs. New
York: Mc Graw-Hill; 2007. h.434-40
53. Gonzalez A, Sosenko IRS, Chandar J, Hummler H, Claure N,
Bancalari E. Influence of infection on patent ductus arteriosus and
chronic lung disease in premature infants weighing 1000 grams or
less. J Pediatr. 1996; 128:470-8
54. Xavier XL, Vargas S, Guerra F, Coronado L. Aplication of new sepsis
definition for evaluate outcome of pediatric patient with severe
systemic infection. Pediatr. 2008: 14;557-60
55. Nora JJ. Muktifactorial inheritance hypothesis for the etiology of
congenital heart disease. Circulation. 1968; XXXVIII:604-18
56. Bhandari V, Zhou G, Bizzarro MJ, Buhimschi C, Hussain N, Gruen JR,
Zhang H. Genetic contribution to patent ductus arteriosus in the
premature newborn. Pediatr. 2009; 123(2):669-73
57. Samanek. Boy:girl ratio in children born with different forms of cardiac
malformation: a population-based study. Pediatr Cardiol. 1994;
15(2):53-7
58. Lary JM, Paulozzi LJ. Sex differences in the prevalence of human birth
